Rafael Pharmaceuticals’ Merger with Rafael Holdings

Martina Bellini
Tagged:

Orrick Herrington & Sutcliffe LLP advised Rafael Pharmaceuticals on the deal.Rafael Pharmaceuticals, a clinical-stage oncology company, announced its proposed merger with Rafael Holdings, Inc., (NYSE: RFL). The…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now